FindTrial
Sign In

FDFN surgical framework system on accurately and minimally invasive surgery of hypertensive intracranial hemorrhage multicenter real world

FDFN surgical framework system on accurately and minimally invasive surgery of hypertensive intracranial hemorrhage multicenter real world

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050681
Enrollment
Unknown
Registered
2021-09-02
Start date
2021-09-20
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive intracranial hemorrhage

Interventions

Experimental group:FDFN surgical framework system
Control group:NA

Sponsors

Tangshan Worker's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Have a clear history of hypertension; 2. Imaging examinations suggest typical bleeding sites, such as basal ganglia, thalamus, cerebellum, and brainstem; 3. Exclude coagulation disorders and blood diseases; 4. CTA/MRA/MRV/DSA examination to exclude other cerebrovascular lesions (choose 1 to 2 examinations); 5. Ultra-early (within 72 hours) or late-stage enhanced MRI to exclude intracranial tumors.

Exclusion criteria

Exclusion criteria: 1. Subjects accepting the other surgery; 2. Existing cerebral lobe hemorrhage; 3. Existing Severe liver and kidney dysfunction; 4. Use antiplatelets or anticoagulant drugs orally; 5. Take part in the other trial within 30 days; 6. Not providing the written ICF.

Design outcomes

Primary

MeasureTime frame
Rate of good prognosis;—

Secondary

MeasureTime frame
Bleeding rate again;—

Countries

China

Contacts

Public ContactCui Jianzhong

Tangshan Worker's Hospital

lwapple168168@sina.cn+86 13932596550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026